INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Grant or awardVerified data

Thiara Parvinder reported ZURA

Director · Zura Bio Ltd · Zura Bio Ltd — Share Option (Right to Buy)

Side
A
Value
—
Shares
38.8K
Price
—
Executed
Jan 23, 2026
Disclosed
Jan 27, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 23 executedJan 27, 2026 disclosed

ZURA · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ZURA

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    15
    NA
    Nirula AjayDirector
    ZURAZura Bio Ltd
    Grant or award
    		A—
    51.0K sh
    		Jun 17, 2026Jun 22, 2026
    traded Jun 17, 2026
    		+5dSEC FORM 4

    Evidence

    15
    TP
    Thiara ParvinderDirector
    ZURAZura Bio Ltd
    Grant or award
    		A—
    51.0K sh
    		Jun 17, 2026Jun 22, 2026
    traded Jun 17, 2026
    		+5dSEC FORM 4

    Evidence

    15
    SJ
    Schoch Steven JDirector
    ZURAZura Bio Ltd
    Grant or award
    		A—
    51.0K sh
    		Jun 17, 2026Jun 22, 2026
    traded Jun 17, 2026
    		+5dSEC FORM 4

    Evidence

    15
    EM
    Eisner MarkDirector
    ZURAZura Bio Ltd
    Grant or award
    		A—
    51.0K sh
    		Jun 17, 2026Jun 22, 2026
    traded Jun 17, 2026
    		+5dSEC FORM 4

    Evidence

    19
    NA
    Nirula AjayDirector
    ZURAZura Bio Ltd
    Grant or award
    		A—
    37.8K sh
    		Feb 21, 2026Mar 5, 2026
    traded Feb 21, 2026
    		+12dSEC FORM 4

    Evidence

    9
    KC
    Kulkarni Sandeep ChidambarDirector, Chief Executive Officer
    ZURAZura Bio Ltd
    Grant or award
    		A—
    2.93M sh
    		Jan 21, 2026Jan 23, 2026
    traded Jan 21, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001995535-26-000006
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 23, 2026
    Published
    Jan 27, 2026
    Ingested by INSIDER
    Nov 5, 04:20 UTC
    Last re-read
    Nov 5, 04:20 UTC

    Extracted facts

    Filer
    Thiara Parvinder
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Zura Bio Ltd — Share Option (Right to Buy)
    Ticker
    ZURA
    Shares
    38.8K
    Price per share
    $0
    Execution date (reported)
    Jan 23, 2026
    Owned after transaction
    38.8K shares
    Days from execution to publication
    4

    What this establishes

    Thiara Parvinder filed this Form 4 reporting a grant or award of ZURA on Jan 23, 2026. It became public on Jan 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Thiara Parvindercik:0001995535
    Issuer
    Zura Bio Ltdcik:0001855644

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.